Enovis Corporation will showcase the latest technologies from its Global Foot and Ankle business at the American College of Foot & Ankle annual meeting in Tampa, Fla., from February 1-4, 2024. The company will feature products from its recent acquisitions of Novastep and the external fixation assets of D.N.E., LLC, along with the internally developed Evolve34 Lapidus Correction System, and the STAR+ Experience with Patient Specific Instrumentation. Being showcased at ACFAS for the first time will be Evolve34, a bunion solution for Lapidus correction that allows surgeons to dial in deformity correction and select a hardware construct specific for the patient’s needs. Additionally, Enovis will be introducing the all new EF1 External Fixation product line, complimenting the flagship DynaNail and DynaClip offerings in the hindfoot segment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ENOV: